Literature DB >> 7027921

Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci.

C N Baker, C Thornsberry, R R Facklam.   

Abstract

The susceptibility of 110 group A and 179 group B streptococci to 25 antimicrobics was tested by broth microdilution and agar disk diffusion tests. Representative strains were used in killing kinetics, penicillin-gentamicin synergy, and minimal bactericidal concentration tests. Group A streptococci were more susceptible than group B streptococci to 17 of the 25 antimicrobics tested. Group A and B streptococci were killed at the same rate if the amount of penicillin used was equivalent to their respective penicillin minimal inhibitory concentrations. Synergism was demonstrated for both group A and B streptococci when penicillin was used at concentrations equal to each respective minimal inhibitory concentration and subinhibitory concentration of gentamicin. This synergy could be demonstrated best using minimal bactericidal concentrations obtained by culturing 3- and 6-h cultures from the microdilution checkerboard tests rather than from 24-h subcultures. A greater synergistic effect was achieved by adding penicillin first and then adding gentamicin rather than in the reverse order, or simultaneously.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7027921      PMCID: PMC181512          DOI: 10.1128/AAC.19.5.716

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI.

Authors:  T C EICKHOFF; J O KLEIN; A K DALY; D INGALL; M FINLAND
Journal:  N Engl J Med       Date:  1964-12-10       Impact factor: 91.245

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

Review 3.  Group B streptococci in human disease.

Authors:  M J Patterson; A El Batool Hafeez
Journal:  Bacteriol Rev       Date:  1976-09

4.  Serious infections in adults due to group B streptococci. Clinical and serotypic characterization.

Authors:  A S Bayer; A W Chow; B F Anthony; L B Guze
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

5.  Presumptive identification and antibiotic susceptibility of group B streptococci.

Authors:  A M Jokipii; L Jokipii
Journal:  J Clin Pathol       Date:  1976-08       Impact factor: 3.411

6.  Recurrence of group B III streptococcal meningitis.

Authors:  S H Walker; A Q Santos; B A Quintero
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

7.  Recurrence of group B streptococcal infection.

Authors:  D D Broughton; W G Mitchell; M Grossman; W K Hadley; M S Cohen
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

8.  Antibiotic-killing kinetics of group B streptococci.

Authors:  V Schauf; A Deveikis; L Riff; A Serota
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

9.  Mechanism of resistance to antibiotic synergism in enterococci.

Authors:  R A Zimmermann; R C Moellering; A N Weinberg
Journal:  J Bacteriol       Date:  1971-03       Impact factor: 3.490

10.  Effect of combinations of penicillin and aminoglycosides on Streptococcus faecalis: a comparative study of seven aminoglycoside antibiotics.

Authors:  E Gutschik; O B Jepsen; I Mortensen
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

View more
  22 in total

1.  A clinical view of vancomycin in 1990.

Authors:  W T Siebert
Journal:  Tex Heart Inst J       Date:  1990

2.  Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program.

Authors:  M Granlund; P Axemo; K Bremme; A-L Bryngelsson; M Carlsson Wallin; C-M Ekström; S Håkansson; B Jacobsson; K Källén; E Spetz; I Tessin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-13       Impact factor: 3.267

3.  Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

Authors:  M Fernandez; M E Hickman; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 4.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

5.  Antimicrobial susceptibility of group B streptococci.

Authors:  K M Persson; A Forsgren
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

6.  Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.

Authors:  C Betriu; M Gomez; A Sanchez; A Cruceyra; J Romero; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

7.  Effect of gentamicin on abscesses caused by Bacteroides species.

Authors:  I Brook; J C Coolbaugh; R I Walker
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

8.  Effect of rifampin on ampicillin killing of group B streptococci.

Authors:  S M Smith; R H Eng; S Landesman
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

9.  Streptococcus agalactiae as a urinary tract pathogen in males and non-pregnant females.

Authors:  B Girgitzova; N Minkov; B Zozikov
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

10.  Streptococcus agalactiae (group B) endocarditis--a description of twelve cases and review of the literature.

Authors:  B E Scully; D Spriggs; H C Neu
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.